Literature DB >> 15126516

A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans.

Cécile Lubrano-Berthelier1, Catherine Le Stunff, Pierre Bougnères, Christian Vaisse.   

Abstract

As a mediator of the effects of leptin, the melanocortin-4 receptor (MC4R) is an essential component of the central regulation of long-term energy homeostasis. Heterozygous mutations in this receptor are the most frequent genetic cause of severe obesity in children. The very rare described carriers of homozygous MC4R mutations for whom clinical data were available had a residual receptor activity thus not allowing for the description of the full extent of the role of MC4R in humans. Here, we present the clinical and biological features of a patient with complete absence of MC4R activity and compare the clinical and endocrine characteristics of this patient with those previously observed in leptin receptor-deficient patients. Our data suggest that in humans, the MC4R mediates most of the anorectic effects of leptin in early childhood. In contrast, MC4R does not mediate the effect of leptin on linear growth and other endocrine axes. In addition, complete MC4R deficiency is not a cause of relative hyperinsulinemia as recently observed in children with heterozygous MC4R mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126516     DOI: 10.1210/jc.2003-031993

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Identification and functional characterization of novel mutations in the melanocortin-4 receptor.

Authors:  Sigri Beckers; Doreen Zegers; Fenna de Freitas; Armand V Peeters; Stijn L Verhulst; Guy Massa; Luc F Van Gaal; Jean-Pierre Timmermans; Kristine N Desager; Wim Van Hul
Journal:  Obes Facts       Date:  2010-10-15       Impact factor: 3.942

2.  Bariatric surgery in a patient with complete MC4R deficiency.

Authors:  I R Aslan; S A Ranadive; B A Ersoy; S J Rogers; R H Lustig; C Vaisse
Journal:  Int J Obes (Lond)       Date:  2010-08-24       Impact factor: 5.095

3.  Several mutations in the melanocortin 4 receptor gene are associated with obesity in Chinese children and adolescents.

Authors:  C L Wang; L Liang; H J Wang; J F Fu; J Hebebrand; A Hinney
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

4.  Pharmacological effect of human melanocortin-2 receptor accessory protein 2 variants on hypothalamic melanocortin receptors.

Authors:  Jinye Liang; Lei Li; Xuanxuan Jin; Bingxin Xu; Linyu Pi; Shangyun Liu; Wei Zhu; Cong Zhang; Bing Luan; Lulu Gong; Chao Zhang
Journal:  Endocrine       Date:  2018-04-27       Impact factor: 3.633

5.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

6.  Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice.

Authors:  James L Smart; Virginie Tolle; Malcolm J Low
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

7.  Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery.

Authors:  Ida J Hatoum; Nicholas Stylopoulos; Amanda M Vanhoose; Kelli L Boyd; Deng Ping Yin; Kate L J Ellacott; Lian Li Ma; Kasia Blaszczyk; Julia M Keogh; Roger D Cone; I Sadaf Farooqi; Lee M Kaplan
Journal:  J Clin Endocrinol Metab       Date:  2012-04-06       Impact factor: 5.958

Review 8.  Lessons from extreme human obesity: monogenic disorders.

Authors:  Sayali A Ranadive; Christian Vaisse
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

9.  The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus.

Authors:  I R Aslan; S A Ranadive; I Valle; S Kollipara; J A Noble; C Vaisse
Journal:  Int J Obes (Lond)       Date:  2013-05-07       Impact factor: 5.095

10.  In silico mutagenesis: a case study of the melanocortin 4 receptor.

Authors:  Yana Bromberg; John Overton; Christian Vaisse; Rudolph L Leibel; Burkhard Rost
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.